177 related articles for article (PubMed ID: 26553673)
1. Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool.
Cibrelus L; Lingani C; Fernandez K; Djingarey MH; Perea WA; Hugonnet S
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S442-50. PubMed ID: 26553673
[TBL] [Abstract][Full Text] [Related]
2. Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014.
Djingarey MH; Diomandé FV; Barry R; Kandolo D; Shirehwa F; Lingani C; Novak RT; Tevi-Benissan C; Perea W; Preziosi MP; LaForce FM
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S434-41. PubMed ID: 26553672
[TBL] [Abstract][Full Text] [Related]
3. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.
Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665
[TBL] [Abstract][Full Text] [Related]
4. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.
Meyer SA; Kambou JL; Cohn A; Goodson JL; Flannery B; Medah I; Messonnier N; Novak R; Diomande F; Djingarey MH; Clark TA; Yameogo I; Fall A; Wannemuehler K
Vaccine; 2015 Mar; 33(12):1492-8. PubMed ID: 25636915
[TBL] [Abstract][Full Text] [Related]
5. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.
Novak RT; Kambou JL; Diomandé FV; Tarbangdo TF; Ouédraogo-Traoré R; Sangaré L; Lingani C; Martin SW; Hatcher C; Mayer LW; Laforce FM; Avokey F; Djingarey MH; Messonnier NE; Tiendrébéogo SR; Clark TA
Lancet Infect Dis; 2012 Oct; 12(10):757-64. PubMed ID: 22818241
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1025-8. PubMed ID: 23254257
[TBL] [Abstract][Full Text] [Related]
7. Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.
; Altmann D; Aseffa A; Bash M; Basta N; Borrow R; Broome C; Caugant D; Clark T; Collard JM; Djingarey M; Goldblatt D; Greenwood B; Griffiths U; Hajjeh R; Hassan-King M; Hugonnet S; Kimball AM; LaForce M; MacLennan C; Maiden MC; Manigart O; Mayer L; Messonnier N; Moisi J; Moore K; Moto DD; Mueller J; Nascimento M; Obaro S; Ouedraogo R; Page AL; Perea W; Pluschke G; Preziosi MP; Sow S; Stephens D; Stuart J; Thomson M; Tiendrebeogo S; Trape JF; Vernet G
Vaccine; 2013 Mar; 31(11):1453-7. PubMed ID: 23273967
[TBL] [Abstract][Full Text] [Related]
8. Communication Challenges During the Development and Introduction of a New Meningococcal Vaccine in Africa.
Berlier M; Barry R; Shadid J; Sirica C; Brunier A; Hasan H; Bouma E
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S451-8. PubMed ID: 26553674
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of emerging vaccines for childhood meningococcal disease.
Choudhuri D; Huda T; Theodoratou E; Nair H; Zgaga L; Falconer R; Luksic I; Johnson HL; Zhang JS; El Arifeen S; Nelson CB; Borrow R; Campbell H; Rudan I
BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S29. PubMed ID: 21501447
[TBL] [Abstract][Full Text] [Related]
10. Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries.
Dellepiane N; Akanmori BD; Gairola S; Jadhav SS; Parker C; Rodriguez C; Srivastava S
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S428-33. PubMed ID: 26553671
[TBL] [Abstract][Full Text] [Related]
11. [Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine].
Nicolas P
Med Sante Trop; 2012; 22(3):246-58. PubMed ID: 23186941
[TBL] [Abstract][Full Text] [Related]
12. The burden of meningococcal meningitis in the African Meningitis Belt, from 2009 to 2014: a trend analysis.
Jaca A; Wiyeh AB; Sambala EZ; Wiysonge CS
Pan Afr Med J; 2021; 39():57. PubMed ID: 34422180
[TBL] [Abstract][Full Text] [Related]
13. Technical Development of a New Meningococcal Conjugate Vaccine.
Frasch CE; Kapre SV; Lee CH; Préaud JM
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S404-9. PubMed ID: 26553667
[TBL] [Abstract][Full Text] [Related]
14. Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt.
Karachaliou A; Conlan AJ; Preziosi MP; Trotter CL
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S594-600. PubMed ID: 26553693
[TBL] [Abstract][Full Text] [Related]
15. The Meningitis Vaccine Project.
LaForce FM; Konde K; Viviani S; Préziosi MP
Vaccine; 2007 Sep; 25 Suppl 1():A97-100. PubMed ID: 17521780
[TBL] [Abstract][Full Text] [Related]
16. Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt.
Carod Artal FJ
Int Health; 2015 Jul; 7(4):226-7. PubMed ID: 25878213
[TBL] [Abstract][Full Text] [Related]
17. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
[TBL] [Abstract][Full Text] [Related]
18. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data.
Trotter CL; Lingani C; Fernandez K; Cooper LV; Bita A; Tevi-Benissan C; Ronveaux O; Préziosi MP; Stuart JM
Lancet Infect Dis; 2017 Aug; 17(8):867-872. PubMed ID: 28545721
[TBL] [Abstract][Full Text] [Related]
19. Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®.
Trotter CL; Cibrelus L; Fernandez K; Lingani C; Ronveaux O; Stuart JM
Vaccine; 2015 Nov; 33(46):6212-7. PubMed ID: 26463444
[TBL] [Abstract][Full Text] [Related]
20. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
Okoko BJ; Idoko OT; Adegbola RA
Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]